Dr. WU
ActiveSummary
Dr. WU has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.7m and a net result of €184,141. Equity is growing by ~6.8% per year across the filed fiscal years. Its solvency ranks better than 82% of 16765 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is < 0.1% (very low).
Checked score
Score 2025
Axes · tick = 2024
Profitability81▼-2
Solvency100=
Growth78=
Track record100
Bankruptcy probability, 12 months
< 0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €140,000 at 30 days acceptable
Liquidity ample (current ratio 9.63 against 9.3 in 2024; short-term debt: 10.4% and cash: 1.1% of total assets), and 10.5% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
89.5%
Return on assets
9.4%
Age of the figures
9 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 11-06-2026, 50 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
50 d early
2024
22 d early
2023
41 d early
2022
12 d early
2021
31 d early
2020
11 d early
2019
24 d early
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 27 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. Usually files around 30 June (5 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsPosition in the running window
29-09-2026 today31-12-2026 close31-07-2027 deadline
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2025, micro schema
Equity
€1.7m▼ 3.9%
2024 · €1.8m
Total assets
€2.0m▼ 4.2%
2024 · €2.0m
Net result
€184,141▼ 18.1%
2024 · €224,852
Working capital
€1.7m▼ 3.8%
2024 · €1.8m
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20212022202320242025
Operating result€130,269▲ 43.6%€141,705▲ 8.8%€230,941▲ 63.0%€295,689▲ 28.0%€219,843▼ 25.7%
Net result€90,034within the sector's middle half▲ 39.8%€100,064within the sector's middle half▲ 11.1%€155,538above the sector's middle half▲ 55.4%€224,852above the sector's middle half▲ 44.6%€184,141above the sector's middle half▼ 18.1%
Equity€1.4mabove the sector's middle half▲ 6.7%€1.5mabove the sector's middle half▲ 7.0%€1.7mabove the sector's middle half▲ 10.1%€1.8mabove the sector's middle half▲ 7.2%€1.7mabove the sector's middle half▼ 3.9%
Total assets€1.6mabove the sector's middle half▲ 5.7%€1.7mabove the sector's middle half▲ 5.6%€1.9mabove the sector's middle half▲ 9.5%€2.0mabove the sector's middle half▲ 9.8%€2.0mabove the sector's middle half▼ 4.2%
Debt€164,404▼ 1.8%€153,553▼ 6.6%€159,210▲ 3.7%€218,820▲ 37.4%€204,049▼ 6.8%
Working capital€1.4mabove the sector's middle half▲ 6.2%€1.5mabove the sector's middle half▲ 6.4%€1.7mabove the sector's middle half▲ 10.8%€1.8mabove the sector's middle half▲ 7.4%€1.7mabove the sector's middle half▼ 3.8%
Solvency89.7%above the sector's middle half▲ 0.8pp90.9%above the sector's middle half▲ 1.2pp91.4%above the sector's middle half▲ 0.5pp89.2%above the sector's middle half▼ 2.2pp89.5%above the sector's middle half▲ 0.3pp
Current ratio25.59above the sector's middle half▼ 8.7723.74above the sector's middle half▼ 1.8511.60above the sector's middle half▼ 12.139.30above the sector's middle half▼ 2.309.63above the sector's middle half▲ 0.33
Return on assets (ROA)5.6%below the sector's middle half▲ 1.4pp5.9%below the sector's middle half▲ 0.3pp8.4%within the sector's middle half▲ 2.5pp11.0%within the sector's middle half▲ 2.7pp9.4%below the sector's middle half▼ 1.6pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2025; 2025 is 26% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.0m
Fixed assets
€4,347 ▲ 13.0%
Current assets
€1.9m ▼ 4.2%
Equity and liabilities €2.0m
Equity
€1.7m ▼ 3.9%
Debt
€204,049 ▼ 6.8%
Debt's share of the balance-sheet total falls from 10.8% to 10.5%. Equity and debt are lower.
Key figures and ratios
EBITDA
€222,943▼
2024 · €297,841
Cash flow
€187,241▼
2024 · €227,004
Debt to equity
0.12▼
2024 · 0.12
ROE
10.5%▼
2024 · 12.4%
Interest coverage
11.95▼
2024 · 33.51
Debt ≤ 1 year
€202,024▼
2024 · €218,435
Income taxes
€77,884▼
2024 · €100,661
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 17,811 companies that looked in July 2024 the way this one looks now, 0.3% went bankrupt within 24 months and 97% are still going.
- Small
- 10 to 20 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.3%
went bankrupt
3.2%
stopped otherwise
97%
still going
For this company itself Checked computes a bankruptcy probability of < 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,338 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 1.0% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.9% |
| 9 | 3.0% | 3.1% |
| 10 | 5.6% | 6.2% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 17,811 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Non-recurring operating income76A | - | - | €56,291 | - | - | - |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €14,297 | €15,081 | €3,223 | €2,152 | €3,100 | ▲ 44.1% |
| Other operating charges640/8 | €3,074 | €3,172 | €1,969 | €1,936 | €3,749 | ▲ 93.6% |
| Non-recurring operating charges66A | - | - | - | €1,756 | - | - |
| Gross operating margin9900 | €147,640 | €159,958 | €236,133 | €301,534 | €226,692 | ▼ 24.8% |
| Operating profit (loss)9901 | €130,269 | €141,705 | €230,941 | €295,689 | €219,843 | ▼ 25.7% |
| Financial income75/76B | €3,697 | €6,335 | €2,049 | €38,711 | €60,839 | ▲ 57.2% |
| Recurring financial income75 | €3,697 | €6,335 | €2,049 | €38,711 | €60,839 | ▲ 57.2% |
| Financial charges65/66B | €5,978 | €6,101 | €10,197 | €8,887 | €18,657 | ▲ 110% |
| Recurring financial charges65 | €5,978 | €6,101 | €10,197 | €8,887 | €18,657 | ▲ 110% |
| Profit (loss) for the period before taxes9903 | €127,988 | €141,939 | €222,793 | €325,513 | €262,026 | ▼ 19.5% |
| Income taxes67/77 | €37,955 | €41,876 | €67,255 | €100,661 | €77,884 | ▼ 22.6% |
| Profit (loss) for the period9904 | €90,034 | €100,064 | €155,538 | €224,852 | €184,141 | ▼ 18.1% |
| Profit (loss) for the period to be appropriated9905 | €90,034 | €100,064 | €155,538 | €224,852 | €184,141 | ▼ 18.1% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €1.6m | €1.7m | €1.9m | €2.0m | €2.0m | ▼ 4.2% |
| Fixed assets21/28 | €113,257 | €101,984 | €6,456 | €3,847 | €4,347 | ▲ 13.0% |
| Tangible fixed assets22/27 | €113,257 | €101,984 | €6,226 | €3,617 | €4,117 | ▲ 13.8% |
| Land and buildings22 | €112,819 | €98,959 | - | - | - | - |
| Plant, machinery and equipment23 | - | - | - | €1,288 | €855 | ▼ 33.6% |
| Furniture and vehicles24 | - | €3,025 | €6,226 | €2,329 | €3,261 | ▲ 40.0% |
| Other tangible fixed assets26 | €439 | - | - | - | - | - |
| Financial fixed assets28 | - | - | €230 | €230 | €230 | = |
| Current assets29/58 | €1.5m | €1.6m | €1.8m | €2.0m | €1.9m | ▼ 4.2% |
| Amounts receivable within one year40/41 | €1,303 | - | - | - | - | - |
| Other amounts receivable41 | €1,303 | - | - | - | - | - |
| Current investments50/53 | €270,000 | €390,000 | €1.5m | €1.5m | €1.9m | ▲ 23.3% |
| Cash at bank and in hand54/58 | €1.2m | €1.1m | €353,758 | €481,163 | €21,975 | ▼ 95.4% |
| Deferred charges and accrued income490/1 | €8,847 | €91,254 | €23,780 | €50,383 | €73,965 | ▲ 46.8% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €1.6m | €1.7m | €1.9m | €2.0m | €2.0m | ▼ 4.2% |
| Equity10/15 | €1.4m | €1.5m | €1.7m | €1.8m | €1.7m | ▼ 3.9% |
| Contributions10/11 | €18,600 | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €1.4m | €1.5m | €1.7m | €1.8m | €1.7m | ▼ 3.9% |
| Non-distributable reserves130/1 | €1,860 | - | - | - | - | - |
| Reserves not available under the articles1311 | €1,860 | - | - | - | - | - |
| Distributable reserves133 | €1.4m | €1.5m | €1.7m | €1.8m | €1.7m | ▼ 3.9% |
| Amounts payable17/49 | €164,404 | €153,553 | €159,210 | €218,820 | €204,049 | ▼ 6.8% |
| Amounts payable after more than one year17 | €106,167 | €85,234 | - | - | - | - |
| Financial debts170/4 | €106,167 | €85,234 | - | - | - | - |
| Amounts payable within one year42/48 | €58,237 | €67,019 | €159,210 | €218,435 | €202,024 | ▼ 7.5% |
| Current portion of amounts payable after more than one year42 | €20,225 | €20,932 | - | - | - | - |
| Trade debts44 | - | - | €1,520 | €1,621 | €538 | ▼ 66.8% |
| Suppliers440/4 | - | - | €1,520 | €1,621 | €538 | ▼ 66.8% |
| Taxes, remuneration and social security45 | €11,846 | €2,475 | €3,008 | €41,701 | €21,283 | ▼ 49.0% |
| Taxes450/3 | €11,846 | €2,475 | €3,008 | €41,701 | €21,283 | ▼ 49.0% |
| Other amounts payable47/48 | €26,167 | €43,611 | €154,682 | €175,113 | €180,203 | ▲ 2.9% |
| Accrued charges and deferred income492/3 | - | €1,300 | - | €385 | €2,025 | ▲ 426% |
| Line | 2021 | 2022 | 2023 | 2024 | 2025 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €90,034 | €100,064 | €155,538 | €224,852 | €184,141 | ▼ 18.1% |
| + Depreciation and write-downs630 | €14,297 | €15,081 | €3,223 | €2,152 | €3,100 | ▲ 44.1% |
| Operating cash flow (approximation) | €104,331 | €115,145 | €158,761 | €227,004 | €187,241 | ▼ 17.5% |
| Investment in fixed assets (approximation) | - | -€3,808 | €92,306 | €457 | -€3,600 | ▼ 888% |
| Change in cash | - | -€100,618 | -€755,803 | €127,406 | -€459,188 | ▼ 460% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-07
State Gazette act
Reappointment: Ka Lung Wu (director)Power of attorney3 facts ▸
State Gazette act
Reappointment: Ka Lung Wu (director)
Power of attorney3 facts ▸
- General meeting, 21-05-2026
- Director reappointment, Ka Lung Wu (director)
- Power of attorney, Swinnen Kristof
11-06
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
09-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2018net €224,852 ▲44.6%
Operating result €295,689, net result €224,852, both a record.
20-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
19-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
30-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
20-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
31-12
Financial
Weakest financial yearnet €64,380 ▼37.5%
Net result drops to €64,380, the lowest in the series; recovery starts the following year.
07-07
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema
2019
11-07
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema
2018
05-07
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema
2017
29-06
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
Financial milestoneState Gazette actNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
1 of 3 acts read
About the unread acts
Of the 3 Belgian State Gazette acts we know for this company, 1 has been read. The other 2 have not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 director, last change in 2026
Ka Lung Wu
CurrentDirector · since 01-07-2026
Derived from published Gazette acts. The CBE keeps the official list of function holders; we do not read it, so the two can differ.
See the function holders in the CBE →
Not every act has been read: a resignation may be missing here
2 of this company's 3 Belgian State Gazette acts have not been read yet. Appointments and resignations recorded in them are missing above: a director who resigned there may therefore still show here as sitting. The acts are in the Timeline.
Location & real-estate footprint
Registered office, Brasschaat · 1 establishment unit since 2006
Ground area
692 m²
Building footprint
118 m²
Volume, LiDAR
740 m³
Parcel 11324D0730/00G008, Flanders · tallest building 10.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
du Boislei 96, 2930 Brasschaat
since 20062.242.658.608
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11324D0730/00G008 | Flanders | 692 m² | 1 · 118 m² | 10.4 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Mandate history
1 person since 2026, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| Ka Lung Wu |
|
Structure & network
Connections & network
1 current directorThe network starts from this company’s directors. Other companies they run appear here as nodes.
This company
Company
Director
Shareholding
+N: links not shown yet
Click a node to look further, drag to arrange, scroll to zoom.
Similar companies · same sector, comparable size
Berad
BE 0885.730.655
Bonheiden · Eq €1,738,577
Dokter Catherine GOOSSEN
BE 0810.810.528
Hove · Eq €1,736,706
Dr. Kristel De Keyzer, nefrologe
BE 0507.754.022
Zonnebeke · Eq €1,736,331
HUBERT-VISION
BE 0817.770.079
Arlon · Eq €1,757,721
DR. GERLINDE ADRIAENSSENS
BE 0479.097.054
Schilde · Eq €1,732,453
Of 16,629 companies in sector 86220 we hold annual accounts for 7,986. 4,900 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded04-12-2006
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
85592Vocational training
85599Other education
E-invoicing
Reachable via Peppol
Peppol ID
0208:0885413327
Also
9925:BE0885413327
Registered
14-12-2025
If you follow this company, Checked tells you the day it leaves the Peppol register.
Register as of 29 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.